DNA Methylation in Major Depressive Disorder

Research output: Chapter in Book/Report/Conference proceedingChapterAcademic

Abstract

Epigenetic mechanisms regulate gene expression, influencing protein levels and ultimately shaping phenotypes during life. However, both stochastic epigenetic variations and environmental reprogramming of the epigenome might influence neurodevelopment and ageing, and this may contribute to the origins of mental ill-health. Studying the role of epigenetic mechanisms is challenging, as genotype-, tissue-and cell type-dependent epigenetic changes have to be taken into account, while the nature of mental disorders also poses significant challenges for linking them with biological profiles. In this chapter, we summarise the current evidence suggesting the role of DNA methylation as a key epigenetic mechanism in major depressive disorder.
Original languageEnglish
Title of host publicationNeuroepigenomics in Aging and Disease
EditorsRaul Delgado-Morales
PublisherSpringer, Cham
Chapter10
Pages185-196
Number of pages12
Volume978
Edition1
ISBN (Electronic)9783319538891
ISBN (Print)9783319538884, 9783319852669
DOIs
Publication statusPublished - 2017

Publication series

SeriesAdvances in Experimental Medicine and Biology
ISSN0065-2598

Keywords

  • Epigenetics
  • DNA methylation
  • Major depressive diorders
  • Antidepressants
  • BDNF PROMOTER METHYLATION
  • SEROTONIN TRANSPORTER GENE
  • ANTIDEPRESSANT TREATMENT
  • NEUROTROPHIC FACTOR
  • ENVIRONMENT INTERACTIONS
  • SLC6A4 METHYLATION
  • STRESS
  • ASSOCIATION
  • PATHOPHYSIOLOGY
  • EXPOSURE

Fingerprint

Dive into the research topics of 'DNA Methylation in Major Depressive Disorder'. Together they form a unique fingerprint.

Cite this